G&E Herbal Biotechnology Statistics

Total Valuation

G&E Herbal Biotechnology has a market cap or net worth of TWD 3.26 billion. The enterprise value is 2.94 billion.

Market Cap	3.26B
Enterprise Value	2.94B

Important Dates

The last earnings date was Friday, November 8, 2024.

Earnings Date	Nov 8, 2024
Ex-Dividend Date	n/a

Share Statistics

G&E Herbal Biotechnology has 59.00 million shares outstanding. The number of shares has increased by 0.10% in one year.

Current Share Class	n/a
Shares Outstanding	59.00M
Shares Change (YoY)	+0.10%
Shares Change (QoQ)	-0.05%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

The trailing PE ratio is 38.92.

PE Ratio	38.92
Forward PE	n/a
PS Ratio	15.45
PB Ratio	4.21
P/TBV Ratio	n/a
P/FCF Ratio	25.23
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 28.48, with an EV/FCF ratio of 22.74.

EV / Earnings	35.08
EV / Sales	13.93
EV / EBITDA	28.48
EV / EBIT	31.50
EV / FCF	22.74

Financial Position

The company has a current ratio of 3.61, with a Debt / Equity ratio of 0.00.

Current Ratio	3.61
Quick Ratio	3.39
Debt / Equity	0.00
Debt / EBITDA	0.02
Debt / FCF	0.02
Interest Coverage	4,059.43

Financial Efficiency

Return on equity (ROE) is 11.20% and return on invested capital (ROIC) is 7.78%.

Return on Equity (ROE)	11.20%
Return on Assets (ROA)	7.09%
Return on Capital (ROIC)	7.78%
Revenue Per Employee	5.71M
Profits Per Employee	2.27M
Employee Count	37
Asset Turnover	0.26
Inventory Turnover	1.80

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +1.78% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+1.78%
50-Day Moving Average	56.37
200-Day Moving Average	55.45
Relative Strength Index (RSI)	41.83
Average Volume (20 Days)	39,478

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, G&E Herbal Biotechnology had revenue of TWD 211.15 million and earned 83.82 million in profits. Earnings per share was 1.42.

Revenue	211.15M
Gross Profit	170.74M
Operating Income	93.37M
Pretax Income	104.80M
Net Income	83.82M
EBITDA	102.56M
EBIT	93.37M
Earnings Per Share (EPS)	1.42

Full Income Statement

Balance Sheet

The company has 324.13 million in cash and 2.21 million in debt, giving a net cash position of 321.92 million or 5.46 per share.

Cash & Cash Equivalents	324.13M
Total Debt	2.21M
Net Cash	321.92M
Net Cash Per Share	5.46
Equity (Book Value)	774.65M
Book Value Per Share	13.13
Working Capital	258.41M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 133.14 million and capital expenditures -3.84 million, giving a free cash flow of 129.30 million.

Operating Cash Flow	133.14M
Capital Expenditures	-3.84M
Free Cash Flow	129.30M
FCF Per Share	2.19

Full Cash Flow Statement

Margins

Gross margin is 80.86%, with operating and profit margins of 44.22% and 39.70%.

Gross Margin	80.86%
Operating Margin	44.22%
Pretax Margin	49.64%
Profit Margin	39.70%
EBITDA Margin	48.57%
EBIT Margin	44.22%
FCF Margin	61.24%

Dividends & Yields

This stock pays an annual dividend of 0.54, which amounts to a dividend yield of 0.97%.

Dividend Per Share	0.54
Dividend Yield	0.97%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	n/a
Buyback Yield	-0.10%
Shareholder Yield	0.88%
Earnings Yield	2.57%
FCF Yield	3.96%

Dividend Details

Stock Splits

The last stock split was on August 20, 2024. It was a forward split with a ratio of 1.06.

Last Split Date	Aug 20, 2024
Split Type	Forward
Split Ratio	1.06

Scores

G&E Herbal Biotechnology has an Altman Z-Score of 21.11.

Altman Z-Score	21.11
Piotroski F-Score	n/a